The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
The pathogenesis of diabetic nephropathy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Structural-functional relationships in diabetic nephropathy.
Mauer, S. M., Steffes, M. W., Ellis, E. N., Sutherland, D. E., Brown, D. M., & Goetz, F. C. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111523 · Cited by 1,209
The Role of Inflammatory Cytokines in Diabetic Nephropathy
Navarro-González, J. F., & Mora-Fernández, C. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091048 · Cited by 932
Advanced Glycosylation End Products in Patients with Diabetic Nephropathy
Makita, Z., Radoff, S., Rayfield, E. J., Yang, Z., Skolnik, E., Delaney, V., Friedman, E. A., Cerami, A., & Vlassara, H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109193251202 · Cited by 918
Podocyte Biology and Response to Injury
Mundel, P., & Shankland, S. J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000039661.06947.fd · Cited by 669
Nephropathy in Patients with Type 2 Diabetes
Remuzzi, G., Schieppati, A., & Ruggenenti, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011773 · Cited by 587
From the Periphery of the Glomerular Capillary Wall Toward the Center of Disease
Wolf, G., Chen, S., & Ziyadeh, F. N. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1626 · Cited by 565
Pathogenesis, prevention, and treatment of diabetic nephropathy
Cooper, M. E. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01346-4 · Cited by 560
Sharma, K., & Ziyadeh, F. N. (1995) · Diabetes · doi:10.2337/diab.44.10.1139 · Cited by 554
A Meta-analysis of the Effects of Nonsteroidal Anti-inflammatory Drugs on Blood Pressure
Pope, J. E. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410040045007 · Cited by 527
Molecular mechanisms of diabetic renal hypertrophy
Wolf, G., & Ziyadeh, F. N. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00590.x · Cited by 472
Mediators of Diabetic Renal Disease: The Case for TGF-β as the Major Mediator
Ziyadeh, F. N. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000093460.24823.5b · Cited by 463
DE VRIESE, A. S., TILTON, R. G., ELGER, M., STEPHAN, C. C., KRIZ, W., & LAMEIRE, N. H. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v125993 · Cited by 442
Pettitt, D. J., Saad, M. F., Bennett, P. H., Nelson, R. G., & Knowler, W. C. (1990) · Diabetologia · doi:10.1007/bf00404096 · Cited by 393
Pathogenesis of the Podocytopathy and Proteinuria in Diabetic Glomerulopathy
Ziyadeh, F., & Wolf, G. (2008) · Current Diabetes Reviews · doi:10.2174/157339908783502370 · Cited by 383
Kiritoshi, S., Nishikawa, T., Sonoda, K., Kukidome, D., Senokuchi, T., Matsuo, T., Matsumura, T., Tokunaga, H., Brownlee, M., & Araki, E. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2570 · Cited by 345
Nephrin Expression Is Reduced in Human Diabetic Nephropathy
Doublier, S., Salvidio, G., Lupia, E., Ruotsalainen, V., Verzola, D., Deferrari, G., & Camussi, G. (2003) · Diabetes · doi:10.2337/diabetes.52.4.1023 · Cited by 344
Imperatore, G., Hanson, R. L., Pettitt, D. J., Kobes, S., Bennett, P. H., & Knowler, W. C. (1998) · Diabetes · doi:10.2337/diabetes.47.5.821 · Cited by 326
Flyvbjerg, A., Dagnæs-Hansen, F., De Vriese, A. S., Schrijvers, B. F., Tilton, R. G., & Rasch, R. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3090 · Cited by 309
Carnosine as a Protective Factor in Diabetic Nephropathy
Janssen, B., Hohenadel, D., Brinkkoetter, P., Peters, V., Rind, N., Fischer, C., Rychlik, I., Cerna, M., Romzova, M., de Heer, E., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2320 · Cited by 291
Ichihara, A., Suzuki, F., Nakagawa, T., Kaneshiro, Y., Takemitsu, T., Sakoda, M., Nabi, A. H. M. N., Nishiyama, A., Sugaya, T., Hayashi, M., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010029 · Cited by 284
Diabetic Nephropathy in 27,805 Children, Adolescents, and Adults With Type 1 Diabetes
Raile, K., Galler, A., Hofer, S., Herbst, A., Dunstheimer, D., Busch, P., & Holl, R. W. (2007) · Diabetes Care · doi:10.2337/dc07-0282 · Cited by 278
Heilig, C. W., Concepcion, L. A., Riser, B. L., Freytag, S. O., Zhu, M., & Cortes, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118226 · Cited by 271
Microvascular basement membranes in diabetes mellitus
Tsilibary, E. C. (2003) · The Journal of Pathology · doi:10.1002/path.1439 · Cited by 267
Cellular and Molecular Mechanisms of Proteinuria in Diabetic Nephropathy
Wolf, G., & Ziyadeh, F. N. (2007) · Nephron Physiology · doi:10.1159/000101797 · Cited by 264
Pathogenesis of diabetic nephropathy
Raptis, A., & Viberti, G. (2001) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2001-18600 · Cited by 256
SUZUKI, D., MIYATA, T., SAOTOME, N., HORIE, K., INAGI, R., YASUDA, Y., UCHIDA, K., IZUHARA, Y., YAGAME, M., SAKAI, H., et al. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v104822 · Cited by 254
Eremina, V., Cui, S., Gerber, H., Ferrara, N., Haigh, J., Nagy, A., Ema, M., Rossant, J., Jothy, S., Miner, J. H., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080810 · Cited by 246
R., L., D., K., A., C., N., T., H., H., P., Z., N., P., D., C., & R., G. (2002) · Diabetologia · doi:10.1007/s00125-002-0946-y · Cited by 228
Hogan, M., Cerami, A., & Bucala, R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115928 · Cited by 209
Mechanisms of Disease: the hypoxic tubular hypothesis of diabetic nephropathy
Singh, D. K., Winocour, P., & Farrington, K. (2008) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0757 · Cited by 202
Diabetes Complications: Why Is Glucose Potentially Toxic?
Porte, D., & Schwartz, M. W. (1996) · Science · doi:10.1126/science.272.5262.699 · Cited by 200
Wnt/β-Catenin Signaling Modulates Survival of High Glucose–Stressed Mesangial Cells
Lin, C.-L., Wang, J.-Y., Huang, Y.-T., Kuo, Y.-H., Surendran, K., & Wang, F.-S. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005121355 · Cited by 192
The Early Natural History of Nephropathy in Type 1 Diabetes
Steinke, J. M., Sinaiko, A. R., Kramer, M. S., Suissa, S., Chavers, B. M., Mauer, M., & for the International Diabetic Nephropathy Study Group (2005) · Diabetes · doi:10.2337/diabetes.54.7.2164 · Cited by 190
Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man
Hohenstein, B., Hausknecht, B., Boehmer, K., Riess, R., Brekken, R. A., & Hugo, C. P. M. (2006) · Kidney International · doi:10.1038/sj.ki.5000294 · Cited by 182
Add-On Anti–TGF-β Antibody to ACE Inhibitor Arrests Progressive Diabetic Nephropathy in the Rat
Benigni, A., Zoja, C., Corna, D., Zatelli, C., Conti, S., Campana, M., Gagliardini, E., Rottoli, D., Zanchi, C., Abbate, M., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000074238.61967.b7 · Cited by 176
Satchell, S. C., Anderson, K. L., & Mathieson, P. W. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000115397.22519.03 · Cited by 174
Kunisaki, M., Bursell, S.-E., Umeda, F., Nawata, H., & King, G. L. (1994) · Diabetes · doi:10.2337/diab.43.11.1372 · Cited by 173
Physiologic and pathophysiologic roles of lipid mediators in the kidney
Hao, C.-M., & Breyer, M. D. (2007) · Kidney International · doi:10.1038/sj.ki.5002192 · Cited by 166
Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23
Vardarli, I., Baier, L. J., Hanson, R. L., Akkoyun, I., Fischer, C., Rohmeiss, P., Basci, A., Bartram, C. R., Van Der Woude, F. J., & Janssen, B. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00663.x · Cited by 165
Sharma, K., Eltayeb, B. O., McGowan, T. A., Dunn, S. R., Alzahabi, B., Rohde, R., Ziyadeh, F. N., & Lewis, E. J. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70037-5 · Cited by 161
High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells
Mishra, R., Emancipator, S. N., Kern, T., & Simonson, M. S. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00058.x · Cited by 158
Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes
DiPetrillo, K., Coutermarsh, B., & Gesek, F. A. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00026.2002 · Cited by 154
Genome-Wide Scans for Diabetic Nephropathy and Albuminuria in Multiethnic Populations
Iyengar, S. K., Abboud, H. E., Goddard, K. A. B., Saad, M. F., Adler, S. G., Arar, N. H., Bowden, D. W., Duggirala, R., Elston, R. C., Hanson, R. L., et al. (2007) · Diabetes · doi:10.2337/db06-1154 · Cited by 151
Molecular Mechanisms of Diabetic Nephropathy and Its Therapeutic Intervention
Yamagishi, S., Fukami, K., Ueda, S., & Okuda, S. (2007) · Current Drug Targets · doi:10.2174/138945007781386884 · Cited by 151
Nguyen, G. (2006) · Kidney International · doi:10.1038/sj.ki.5000265 · Cited by 144
Plasma Prorenin Activity and Complications in Children with Insulin-Dependent Diabetes Mellitus
Wilson, D. M., & Luetscher, J. A. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010183231604 · Cited by 141
Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes
Harris, R. D., Steffes, M. W., Bilous, R. W., Sutherland, D. E. R., & Mauer, S. M. (1991) · Kidney International · doi:10.1038/ki.1991.187 · Cited by 140
Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy
Benigni, A., Gagliardini, E., Tomasoni, S., Abbate, M., Ruggenenti, P. L., Kalluri, R., & Remuzzi, G. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00636.x · Cited by 132
Nagai, Y., Yao, L., Kobori, H., Miyata, K., Ozawa, Y., Miyatake, A., Yukimura, T., Shokoji, T., Kimura, S., Kiyomoto, H., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080649 · Cited by 128
Mauer, S. M., Steffes, M. W., Connett, J., Najarian, J. S., Sutherland, D. E. R., & Barbosa, J. J. (1983) · Diabetes · doi:10.2337/diab.32.10.948 · Cited by 127
Intravenous Administration of Hepatocyte Growth Factor Gene Ameliorates Diabetic Nephropathy in Mice
Dai, C., Yang, J., Bastacky, S., Xia, J., Li, Y., & Liu, Y. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000139479.09658.ee · Cited by 117
Role of oxidative stress in diabetic nephropathy
Vasavada, N., & Agarwal, R. (2005) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2005.01.001 · Cited by 114
Ichinose, K., Kawasaki, E., & Eguchi, K. (2007) · American Journal of Nephrology · doi:10.1159/000107758 · Cited by 113
Kunz, R., Bork, J. P., Fritsche, L. G., Ringel, J., & Sharma, A. M. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v991653 · Cited by 111
Jones, S. G., Jones, S., & Phillips, A. O. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590051739.x · Cited by 104
Boright, A. P., Paterson, A. D., Mirea, L., Bull, S. B., Mowjoodi, A., Scherer, S. W., & Zinman, B. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1238 · Cited by 102
Jeffers, B. W., Estacio, R. O., Raynolds, M. V., & Schrier, R. W. (1997) · Kidney International · doi:10.1038/ki.1997.355 · Cited by 100
Impact of mitochondrial ROS production on diabetic vascular complications
Nishikawa, T., Kukidome, D., Sonoda, K., Fujisawa, K., Matsuhisa, T., Motoshima, H., Matsumura, T., & Araki, E. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.01.031 · Cited by 100
Diabetic nephropathy: Linking histology, cell biology, and genetics
Adler, S. G. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00988.x · Cited by 91
Eicosanoids and renal vascular function in diseases
Imig, J. D. (2006) · Clinical Science · doi:10.1042/cs20050251 · Cited by 90
DiPetrillo, K., & Gesek, F. A. (2004) · American Journal of Nephrology · doi:10.1159/000079121 · Cited by 87
Movva, S., Alluri, R. V., Komandur, S., Vattam, K. K., Eppa, K., Mukkavali, K. K., Mubigonda, S., Saharia, S., Shastry, J. C., & Hasan, Q. A. (2007) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2006.07.001 · Cited by 84
Roles of Lipid Mediators in Kidney Injury
Hao, C., & Breyer, M. D. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.02.008 · Cited by 39
Cited by
Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
Samsu, N. (2021) · BioMed Research International · doi:10.1155/2021/1497449 · Cited by 1,001
Vascular Complications of Diabetes: Mechanisms of Injury and Protective Factors
Rask-Madsen, C., & King, G. L. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.11.012 · Cited by 846
Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
Zheng, H., Whitman, S. A., Wu, W., Wondrak, G. T., Wong, P. K., Fang, D., & Zhang, D. D. (2011) · Diabetes · doi:10.2337/db11-0807 · Cited by 507
New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism
Eid, S., Sas, K. M., Abcouwer, S. F., Feldman, E. L., Gardner, T. W., Pennathur, S., & Fort, P. E. (2019) · Diabetologia · doi:10.1007/s00125-019-4959-1 · Cited by 468
Gupta, S., Dominguez, M., & Golestaneh, L. (2023) · Medical Clinics of North America · doi:10.1016/j.mcna.2023.03.004 · Cited by 337
Metadata
- Authors
- Dronavalli, S., Duka, I., & Bakris, G. L.
- Venue
- Nature Clinical Practice Endocrinology & Metabolism
- Published
- 2008-07-08
- Volume
- 4
- Issue
- 8
- Pages
- 444-452
- ISSN
- 1745-8366 (ISSN-L)
- 1745-8374
- OpenAlex
- W2054393454
- Cited by
- 625
- References
- 64
- FWCI
- 15.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.